The development of complex and effective therapies has improved outcomes in breast cancer, highlighting the need for strategies to escalate and de-escalate treatment. In this exclusive VJSession, Roberto Salgado, MD (GZA Ziekenhuizen Campus Sint-Augustinus, Wilrijk, Belgium) and Marleen Kok, MD (Netherlands Cancer Institute, Amsterdam, Netherlands) discuss the latest advances in triple-negative breast cancer (TNBC), including treatment de-escalation and associated biomarkers, as well as the emerging role of tumor-infiltrating lymphocytes (TILs).

The Breast Cancer Podcasts on VJOncology are supported by Seagen. Seagen have no influence over the production of the content.